SEARCH

SEARCH BY CITATION

References

  • 1
    Polyak K,Lee M-H,Erdjument-Bromage H,Koff A,Roberts JM,Tempst P,Massagué J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 5966.
  • 2
    Toyoshima H,Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 6774.
  • 3
    Kato JY,Matsuoka M,Polyak K,Massague J,Sherr CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 1994; 79: 48796.
  • 4
    Sherr CJ,Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 150112.
  • 5
    Pagano M,Tam SW,Theodoras AM,Beer-Romero P,Del Sal G,Chau V,Yew PR,Draetta GF,Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269: 6825.
  • 6
    Viglietto G,Motti ML,Bruni P,Melillo RM,D'Alessio A,Califano D,Vinci F,Chiappetta G,Tsichlis P,Bellacosa A,Fusco A,Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002; 8: 113644.
  • 7
    Shin I,Yakes FM,Rojo F,Shin NY,Bakin AV,Baselga J,Arteaga CL. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 2002; 8: 114552.
  • 8
    Liang J,Zubovitz J,Petrocelli T,Kotchetkov R,Connor MK,Han K,Lee JH,Ciarallo S,Catzavelos C,Beniston R,Franssen E,Slingerland JM. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8: 115360.
  • 9
    Pietenpol JA,Bohlander SK,Sato Y,Papadopoulos N,Liu B,Friedman C,Trask BJ,Roberts JM,Kinzler KW,Rowley JD,Vogelstein B. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995; 55: 120610.
  • 10
    Ponce-Castañeda MV,Lee M-H,Latres E,Polyak K,Lacombe L,Montgomery K,Mathew S,Krauter K,Sheinfeld J,Massague J,Cordon-Cardo C. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995; 55: 12114.
  • 11
    Spirin KS,Simpson JF,Takeuchi S,Kawamata N,Miller CW,Koeffler HP. p27/Kip1 mutation found in breast cancer. Cancer Res 1996; 56: 24004.
  • 12
    Catzavelos C,Bhattacharya N,Ung YC,Wilson JA,Roncari L,Sandhu C,Shaw P,Yeger H,Morava-Protzner I,Kapusta L,Franssen E,Pritchard KI, et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nature Med 1997; 3: 22730.
  • 13
    Porter PL,Malone KE,Heagerty PJ,Alexander GM,Gatti LA,Firpo EJ,Daling JR,Roberts JM. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997; 3: 2225.
  • 14
    Tan P,Cady B,Wanner M,Worland P,Cukor B,Magi-Galluzzi C,Lavin P,Draetta G,Pagano M,Loda M. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 1997; 57: 125963.
  • 15
    Mori M,Mimori K,Shiraishi T,Tanaka S,Ueo H,Sugimachi K,Akiyoshi T. p27 expression and gastric carcinoma. Nat Med 1997; 3: 593.
  • 16
    Loda M,Cukor B,Tam SW,Lavin P,Fiorentino M,Draetta GF,Jessup JM,Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997; 3: 2314.
  • 17
    Newcomb EW,Sosnow M,Demopoulos RI,Zeleniuch-Jacquotte A,Sorich J,Speyer JL. Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors. Am J Pathol 1999; 154: 11925.
  • 18
    Sui L,Tokuda M,Ohno M,Hatase O,Hando T. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors. Gynecol Oncol 1999; 73: 2029.
  • 19
    Masciullo V,Sgambato A,Pacilio C,Pucci B,Ferrandina G,Palazzo J,Carbone A,Cittadini A,Mancuso S,Scambia G,Giordano A. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res 1999; 59: 37904.
  • 20
    Tsihlias J,Kapusta LR,DeBoer G,Morava-Protzner I,Zbieranowski I,Bhattacharya N,Catzavelos GC,Klotz LH,Slingerland JM. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998; 58: 5428.
  • 21
    Cote RJ,Shi Y,Groshen S,Feng AC,Cordon-Cardo C,Skinner D,Lieskovosky G. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst 1998; 90: 91620.
  • 22
    Sgambato A,Migaldi M,Faraglia B,Garagnani L,Romano G,De Gaetani C,Ferrari P,Capelli G,Trentini GP,Cittadini A. Loss of p27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. Cancer Res 1999; 59: 324550.
  • 23
    Korkolopoulou P,Christodoulou P,Konstantinidou AE,Thomas-Tsagli E,Kapralos P,Davaris P. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Hum Pathol 2000; 31: 75160.
  • 24
    Kamai T,Takagi K,Asami H,Ito Y,Oshima H,Yoshida KI. Decreasing of p27Kip1 and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Br J Cancer 2001; 84: 124251.
  • 25
    Ogawa K,Kimoto N,Asamoto M,Nakanishi M,Takahashi S,Shirai T. Aberrant expression of p27Kip1 is associated with malignant transformation of the rat urinary bladder epithelium. Carcinogenesis 2000; 21: 11721.
  • 26
    Nakayama K,Ishida N,Shirane M,Inomata A,Inoue T,Shishido N,Horii I,Loh DY,Nakayama K-I. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85: 70720.
  • 27
    Cohen SM. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol Pathol 2002; 30: 66371.
  • 28
    Ogawa K,Uzvolgyi É,St. John MK,de Oliveira ML,Arnold L,Cohen SM. Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in B6D2F1 mice. Mol Carcinog 1998; 21: 709.
  • 29
    Fukushima S,Imaida K,Sakata T,Okamura T,Shibata M-A,Ito N. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res 1983; 43: 44547.
  • 30
    Fero ML,Randel E,Gurley KE,Roberts JM,Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumor suppression. Nature 1998; 396: 17780.
  • 31
    Doganay L,Altaner S,Bilgi S,Kaya E,Ekuklu G,Kutlu K. Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior? Int Urol Nephrol 2003; 35: 1818.
  • 32
    Philipp J,Vo K,Gurley KE,Seidel K,Kemp CJ. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene 1999; 18: 468998.
  • 33
    Jackson RJ,Adnane J,Coppola D,Cantor A,Sebti SM,Pledger WJ. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 2002; 21: 848697.
  • 34
    Di Cristofano A,De Acetis M,Koff A,Cordon-Cardo C,Pandolfi PP. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 2001; 27: 2224.
  • 35
    Shaffer DR,Viale A,Ishiwata R,Leversha M,Olgac S,Manova K,Satagopan J,Scher H,Koff A. Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proc Natl Acad Sci USA 2005; 102: 2105.
  • 36
    Pellegata NS,Quintanilla-Martinez L,Siggelkow H,Samson E,Bink K,Höfler H,Fend F,Graw J,Atkinson MJ. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 2006; 103: 1555863.
  • 37
    Bryant P,Zheng Q,Pumiglia K. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. Mol Cell Biol 2006; 26: 420113.
  • 38
    Ogino S,Kawasaki T,Kirkner GJ,Yamaji T,Loda M,Fuchs CS. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol 2007; 20: 1522.
  • 39
    Min YH,Cheong JW,Kim JY,Eom JI,Lee ST,Hahn JS,Ko YW,Lee MH. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Res 2004; 64: 522531.
  • 40
    Besson A,Hwang HC,Cicero S,Donovan SL,Gurian-West M,Johnson D,Clurman BE,Dyer MA,Roberts JM. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 2007; 21: 173146.